Olfactory Training in Various Populations
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Oct 30, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Study Objectives: The overall, primary goals of these studies are as follows:
1. To compare the outcomes of our olfactory testing battery for olfactory training to the previously published literature
2. To determine if using a larger panel of odorants (our 15 scents versus the 4 scents previously used in the literature) yields a significant difference in olfactory recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18-80
- • Quantifiable or subjective olfactory dysfunction
- • ability to complete objective olfactory tests and comply with olfactory training protocol
- Exclusion Criteria:
- • Anyone lower than the age of 18, or greater than the age of 80
- • Pregnant women, as sinonasal symptoms and changes in smell can occur in pregnancy and are multifactorial
- • Patients with poor or questionable compliance, as participation requires daily compliance with study protocol
- • Patient's that are unable to perform routine follow-up
- • Patients who are participating in another study during this trial
- • Patients with dementia, Alzheimer's disease, Parkinson's disease, or other neurocognitive disorders, as these conditions are associated with baseline olfactory dysfunction.
- • Patients with other systemic conditions known to impact the sinonasal cavity such as Wegener's granulomatosis, Churg Strauss, and immunodeficiency, as their impact on olfaction is unknown
- • Patients who are allergic to any of the smells or components of our olfactory testing and training
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Patients applied
Trial Officials
Jennifer A Villwock, MD
Principal Investigator
University of Kansas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported